Ropeginterferon Alfa-2b

Ropeginterferon Alfa-2b for MDS/MPN Overlap Syndromes, Including CMML and MDS/MPN-RS-T

More Information

Trial Status
Not yet accepting
Trial Phase
Phase 2
Enrollment
35 patients (estimated)
Tags
Interferon Alfa-2b
Trial Type
Treatment
Last Update
SparkCures ID
2239
NCT Identifier
NCT07468916

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.